TIPPS: Thrombophilia in Pregnancy Prophylaxis Study
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The TIPPS trial seeks to determine the safety and effectiveness of low-molecular-weight
heparin (LMWH), an anticoagulant, in preventing placenta mediated pregnancy complications and
venous thromboembolism (VTE) in women with thrombophilia. Thus, the principal research
question is: can LMWH prevent thrombosis in the leg veins, pulmonary arteries and placental
vessels, thereby reducing the risk of deep vein thrombosis, pulmonary embolism (PE),
intrauterine growth restriction (IUGR), preeclampsia, miscarriage and stillbirth?